Shigeru Torii

Title: Shigeru Torii: Innovator in Beta-Lactam Compounds

Introduction

Shigeru Torii is a prominent inventor based in Okayama-ken, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of beta-lactam compounds. With a total of 16 patents to his name, Torii's work has had a lasting impact on antibiotic synthesis.

Latest Patents

One of Torii's latest patents is focused on a process for preparing 3-halogenated cephem derivatives and beta-lactam compounds. The objective of this invention is to provide a beta-lactam compound and a 2-substituted methyl-3-cephem compound, both of which serve as valuable intermediates for the synthesis of cephem antibiotics. The beta-lactam compound can be represented by a specific general formula, where various groups are defined, including protected amino groups and aryl groups. Similarly, the 2-substituted methyl-3-cephem compound is also represented by a general formula with defined substituents.

Career Highlights

Throughout his career, Shigeru Torii has worked with notable companies, including Otsuka Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Factory, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of new medicinal compounds.

Collaborations

Torii has collaborated with esteemed colleagues such as Hideo Tanaka and Takashi Shiroi. These partnerships have facilitated the exchange of ideas and advancements in their shared field of research.

Conclusion

Shigeru Torii's contributions to the field of beta-lactam compounds and his extensive patent portfolio highlight his role as a key innovator in pharmaceuticals. His work continues to influence the development of antibiotics and improve healthcare outcomes.